相似文献
1
Morphine and alternative opioids in cancer pain: the EAPC recommendations.
Br J Cancer. 2001 Mar 2;84(5):587-93. doi: 10.1054/bjoc.2001.1680.
2
[Morphine and alternative opioids in cancer pain: the EAPC recommendations].
Schmerz. 2002 Jun;16(3):186-93. doi: 10.1007/s004820100104.
3
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
4
[Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].
Ann Fr Anesth Reanim. 2007 Jun;26(6):502-15. doi: 10.1016/j.annfar.2007.03.029. Epub 2007 Jun 8.
5
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
Eur J Pain. 2005 Oct;9(5):571-9. doi: 10.1016/j.ejpain.2004.12.003. Epub 2005 Jan 20.
6
[Use of opioids against severe cancer pain].
Tidsskr Nor Laegeforen. 2004 Feb 5;124(3):337-8.
7
Opioid therapy for chronic painful conditions.
Med Health R I. 2001 Oct;84(10):323-6.
8
Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Cancer. 1996 Aug 15;78(4):852-7. doi: 10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T.
9
Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
J Palliat Med. 2013 Jul;16(7):809-12. doi: 10.1089/jpm.2011.0502. Epub 2012 Aug 27.
10
Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
Pain Physician. 2008 Mar;11(2 Suppl):S5-S62.
引用本文的文献
1
Profiling Postpartum Recovery After Scheduled Cesarean Delivery With Neuraxial Anesthesia: A Longitudinal Cohort Study.
Anesth Analg. 2025 Apr 4. doi: 10.1213/ANE.0000000000007476.
2
Reflecting on Cancer Pain as Constant Acute Pain, not Chronic Pain. 'Known Knowns, Known Unknowns, Unknown Unknowns'.
Curr Oncol Rep. 2025 May;27(5):584-600. doi: 10.1007/s11912-025-01642-w. Epub 2025 Apr 3.
3
Opioid Utilisation in Hungary: National and Regional Analysis in Ambulatory and Hospital Care Sector.
J Clin Med. 2025 Jan 29;14(3):897. doi: 10.3390/jcm14030897.
4
Incidence of Delirium during the Initiation Phase of Morphine and Hydromorphone Therapy in Cancer Patients: A Retrospective Comparative Study.
Can J Hosp Pharm. 2025 Jan 15;78(1):e3515. doi: 10.4212/cjhp.3515. eCollection 2025.
5
Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?
Pharmacogenomics. 2024;25(14-15):579-586. doi: 10.1080/14622416.2024.2430161. Epub 2024 Dec 4.
6
Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society's recommendations for best clinical practice.
Br J Pain. 2024 Sep 7:20494637241280356. doi: 10.1177/20494637241280356.
7
Complication avoidance, rehabilitation, pain therapy and palliative care for patients with metastatic spine tumors: WFNS spine committee recommendations.
Neurosurg Rev. 2024 Oct 30;47(1):830. doi: 10.1007/s10143-024-03050-3.
8
A real-world study of the quality of Outpatient Pain Management in patients with Cancer.
J Cancer Surviv. 2024 May 25. doi: 10.1007/s11764-024-01621-3.
9
Scheduled and Breakthrough Opioid Use for Cancer Pain in an Inpatient Setting at a Tertiary Cancer Hospital.
Curr Oncol. 2024 Mar 5;31(3):1335-1347. doi: 10.3390/curroncol31030101.
10
Palliative Care in Drug Resistance Tuberculosis: An Overlooked Component in Management.
Indian J Palliat Care. 2023 Oct-Dec;29(4):388-393. doi: 10.25259/IJPC_141_2022. Epub 2023 Nov 11.
本文引用的文献
1
Opioids in pain management.
Lancet. 1999 Jun 26;353(9171):2229-32. doi: 10.1016/S0140-6736(99)03528-X.
2
Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home.
Cancer. 1999 Apr 15;85(8):1849-58. doi: 10.1002/(sici)1097-0142(19990415)85:8<1849::aid-cncr27>3.0.co;2-6.
3
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
Pain. 1999 Feb;79(2-3):303-12. doi: 10.1016/s0304-3959(98)00179-1.
4
Problems of long-term spinal opioid treatment in advanced cancer patients.
Pain. 1999 Jan;79(1):1-13. doi: 10.1016/S0304-3959(98)00118-3.
5
Peak plasma concentrations after oral morphine: a systematic review.
J Pain Symptom Manage. 1998 Dec;16(6):388-402. doi: 10.1016/s0885-3924(98)00094-3.
6
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
J Clin Oncol. 1998 Oct;16(10):3222-9. doi: 10.1200/JCO.1998.16.10.3222.
7
Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
J Clin Oncol. 1998 Oct;16(10):3216-21. doi: 10.1200/JCO.1998.16.10.3216.
8
Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats.
J Pain Symptom Manage. 1998 Apr;15(4):253-7. doi: 10.1016/s0885-3924(97)00371-0.
9
Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
Pain. 1997 Feb;69(3):295-302. doi: 10.1016/S0304-3959(96)03269-1.
10
Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients.
J Clin Oncol. 1996 Oct;14(10):2836-42. doi: 10.1200/JCO.1996.14.10.2836.
Zotero 插件